CD274 and neoplasm: However, there are still limitations to the use of PD-L1 expression levels for evaluating responses to immune checkpoint blockade; these include the lack of standardization for both, detection methods for the heterogeneous expression of PD-L1 in the tumor microenvironment and definition of PD-L1 positivity (61).